Growth Metrics

Conmed (CNMD) Profit After Tax (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Conmed 1.06 Bn 1.02 Bn 183.45 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -17.39%
Dec 31, 2025 485.48%
Sep 30, 2025 -86.65%
Jun 30, 2025 254.89%
Mar 31, 2025 -82.12%
Dec 31, 2024 -31.09%
Sep 30, 2024 63.41%
Jun 30, 2024 52.09%
Mar 31, 2024 -40.40%
Dec 31, 2023 108.82%
Sep 30, 2023 15.33%
Jun 30, 2023 654.92%
Mar 31, 2023 -93.16%
Dec 31, 2022 -42.40%
Sep 30, 2022 127.42%
Jun 30, 2022 -1,223.81%
Mar 31, 2022 -38.74%
Dec 31, 2021 63.53%
Sep 30, 2021 12.48%
Jun 30, 2021 34.79%
Mar 31, 2021 -59.15%
Dec 31, 2020 252.41%
Sep 30, 2020 125.00%
Jun 30, 2020 -562.29%
Mar 31, 2020 -60.31%
Dec 31, 2019 114.25%
Sep 30, 2019 22.39%
Jun 30, 2019 457.79%
Mar 31, 2019 -93.48%
Dec 31, 2018 168.72%
Sep 30, 2018 -33.19%
Jun 30, 2018 -18.19%
Mar 31, 2018 -77.18%
Dec 31, 2017 548.83%
Sep 30, 2017 17.23%
Jun 30, 2017 235.07%
Mar 31, 2017 -167.75%
Dec 31, 2016 -8.57%
Sep 30, 2016 154.40%
Jun 30, 2016 227.33%
Mar 31, 2016 -128.85%
Dec 31, 2015 -11.51%
Sep 30, 2015 18.93%
Jun 30, 2015 18.20%
Mar 31, 2015 -44.33%
Dec 31, 2014 475.00%
Sep 30, 2014 -80.77%
Jun 30, 2014 18.88%
Mar 31, 2014 -15.65%
Dec 31, 2013 79.83%
Sep 30, 2013 -40.34%
Jun 30, 2013 -9.14%
Mar 31, 2013 -3.72%
Dec 31, 2012 16.92%
Sep 30, 2012 -9.48%
Jun 30, 2012 3.29%
Mar 31, 2012 139.66%
Dec 31, 2011 -406.10%
Sep 30, 2011 -5.40%
Jun 30, 2011 -3.50%
Mar 31, 2011 29.18%
Dec 31, 2010 -20.50%
Sep 30, 2010 19.87%